Dublin, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The "Psoriatic Arthritis - Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering. The latest report on ...
AbbVie has submitted an application to the FDA for review of upadacitinib in the treatment of active psoriatic arthritis (PsA) in adults. AbbVie has submitted an application to the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback